Sponsors & Exhibitors


Takeda Pharmaceutical Company Limited is a global, research- and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries.



The Association for Training, Education and Research in Hematology, Immunology and Transplantation (ATERHIT) is a non-for profit scientific organization based in Paris (France).

ATERHIT aims to promote clinical, translational and basis research in the fields of hematology, immunology and stem cell transplantation through direct or indirect support to research projects. It also organizes a board portfolio of educational activities with the goal to disseminate knowledge in its fields of interest and enhance collaborations among all stakeholders. ATERHIT provides support for students, fellows, junior doctors, nurses, and other healthcare professionals who wish to train or gain more experience in this field. The organization can distribute prizes to acknowledge some major achievements in these fields.


ATERHIT (Association for Training, Education, and Research in Hematology, Immunology and Transplantation)

Hôpital Saint Antoine, Service hématologie
184 rue du Faubourg Saint Antoine, 75012 PARIS, France

Tel : 02 40 09 72 26 or 06 59 66 34 07 Email : aterhit@yahoo.fr

Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, fibrotic diseases and rheumatoid arthritis. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
BMS Medical - Oncology
3401 Princeton Pike, Lawrenceville, NJ 08648
Office: 609.302.3808 


Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. We seek to deliver truly innovative and life-changing drugs for our patients through the discovery, development, and commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. Celgene employs more than 8,000 employees worldwide.
full company name: Celgene
mailing address: Route de Perreux 1 - 2017 Boudry - Switzerland
telephone: +41 32 729 85 00
website: www.celgene.com


At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at www.janssen.com/emea. Follow us at www.twitter.com/janssenEMEA.
Company website: http://www.janssen.com/emea

Sanofi Genzyme
The need for new cancer medicines remains great, and we are committed to
helping to address this need. Sanofi has a strong heritage in oncology and
has laid out a strategy to re-establish itself as a leader in cancer treatment. Now
as part of Sanofi Genzyme, we are concentrating on building our oncology
business and currently provide important options for patients. We also have a
special focus on the promising field of immuno-oncology in which a patient’s
immune system is used to fight cancer cells. We are building a pipeline of
potential treatments based on this approach through partnerships with
researchers and other companies.


Genzyme Europe B.V.
Gooimeer 10
The Netherlands
TEL.: +31 (0) 35 699 1200
FAX: +31 (0)35 694 3214



Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Our belief—and the core of our strategy—is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen (Europe) GmbH 
Dammstr. 23, 6300 Zug
+41 41 369 03 00

Neopharm Israel

Neopharm Israel is dedicated to the marketing and sales of premium ethical prescription products – pharmaceuticals, orphan drugs and biologic drugs.
Neopharm Israel is the exclusive representative and partner of leading multinational bio-pharma and consumer healthcare brands including Alexion, Celgene, Fresenius and many more

Neopharm Israel
Tel: +972-3-937-3783
Fax: +972-3-937-3770
E-Mail: bd@neopharmgroup.com
URL: http://neopharmgroup.com/



airinspace® develop, manufacture and supply a unique range of mobile air decontamination units  and associated protected environment to protect immunocompromised and high risk patients in hematology, transplant and intensive care units. Benefits of airinspace’ products have been demonstrated accross several scientific papers published in peer review.  We also provide hospitals with dry mist fogging technology for surface disinfection as a highly effective process for infectious outbreak containment, disinfection of AIIRs and preparation of protected environments for immunocompromised patients. The quality system of Airinspace is ISO 9001 certified, products bear Origine France Garantie label. Air decontamination units are certified ISO 13485. 


14 rue Jean Monnet
78990 ELANCOURT- France
Tel +33 1 30 07 01 01
Fax +33 1 30 07 01 02

Binding Site

Binding Site is committed to improving patient lives worldwide through education, collaboration and innovation. Discover how your multiple myeloma patients could benefit from Binding Site’s Freelite® and Hevylite® assays.
Freelite, supported by more than 17 years of clinical evidence, is the state of the art in free light chain testing and the ONLY serum free light chain test recommended by international and national guidelines for diagnosis and monitoring. The complementary Hevylite test can help with “difficult-to-monitor” myeloma patients and adds unique information on immune suppression.
Using Freelite and Hevylite together is an optimal multiple myeloma monitoring strategy.

Visit Booth 7 

Binding Site 
8 Calthorpe road, 
B15 1QT 
Tel: + 44 (0) 121 456 9500
Fax: +44 (0) 121 456 9749
E-mail: info@bindingsite.co.uk
Web site: www.bindingsite.com



Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on novel agents directed against nuclear transport and related targets to treat cancer and other diseases. Karyopharm's SINE compounds inhibit nuclear export to restore normal localization of tumor suppressor proteins and reduce levels of proteins that repress death of cancer cells. Evaluation of Karyopharm’s lead compound, selinexor, is ongoing in phase 2 and 3 studies for multiple myeloma, DLBCL, endometrial cancer, and liposarcoma. To date, over 2,300 patients with a broad range of hematologic and solid tumor malignancies have been treated with selinexor.

Ontime Courier GmbH


Email:  samples@ontimecourier.com
Phone (with country code):  + 49 – 89 -35 73 73 - 70
Website: www.ontimecourier.com

Pharma/Life Science shipment at Ontime Courier stands out due to highly customized transport arrangements concerning your pharmaceuticals or blood and tissue samples deriving from humans and/or animals.
Qualified Thermo-Container-Solutions (including temperature control on demand) ensure thermal stability of your transported good. Open source logistical solutions in combination with reviewed logistical partners guarantee bespoke routing for your important shipment.
Prompt response of our well-trained team concerning your request enables quick decisions on your part.
The combination of reliable and qualified logistical partners providing Onboard, Same Day and Next Day, assure expedited transportation service combined with a decent ratio of price and performance.
Throughout the transportation process, our coordination team personally checks all critical handovers in order to ensure top performance (“Proactive Shipment Management”).
24/7/365 – multi lingual staff – online tracking – we cover all your needs. samples@ontimecourier.com or +49-89-357373-70 – contact us to find out more!

Full Company Name:
Ontime Courier GmbH
Mailing Address:
Alois-Wolfmüller-Str. 8
80939 Munich
telephone, fax, email and URL
Phone: +49 89 357373-70
Fax: +49 89 357373-35



Sebia a global specialty diagnostic company, develops, manufactures and commercializes IVD tests and analyzers dedicated to the in vitro diagnosis of cancer, inflammatory diseases, diabetes and hemoglobin disorders. Sebia’s focus on electrophoresis techniques enables it to maintain a sustained R&D program, providing access to genuine innovations in any lab. Both agarose gel and capillary assays, and their dedicated automation, are designed to be integrated into the same routine workflow; for gel (Assist, Hydrasys 2 Scan) and for capillary electrophoresis (Capillarys 3 TERA, stand alone or in work cell configuration up to three instruments with tube loader, Capillarys 2 Flex Piercing, Minicap Flex Piercing). More recently Sebia completed its Myeloma product line, with two important additions, Hydrashift daratumumab, reagent to be used with the Hydragel IF test to mitigate the DARZALEX® interference, and two new generations sFLC assays, Seralite serum and Sebia FLC kappa and lambda kits.

Parc Technologique Léonard de Vinci
27 rue Léonard de Vinci
CP 8010 Lisses – 91008 EVRY Cedex
Tel: 01 69 89 80 80
Email: sebia@sebia.com